Search bioRxiv⌕ Search

Biology subjects

Ramakrishnan, A.-B.

Publications and source records attributed to Ramakrishnan, A.-B..

2 recordsLinked to original sources

Intercellular trafficking of latent TGF-β1 converts integrin expressing cells into signaling relays

TGF-{beta}1 is secreted as a latent complex tethered to the cell surface by milieu molecules such as GARP, and its activation requires direct engagement by integrin-expressing cells. How this interaction converts the latent complex into signaling-competent growth factor (GF) remains unclear. Here we show that contact between GARP/TGF-{beta}1-presenting cells and cells expressing integrin V{beta}6 or V{beta}8 triggers rapid trogocytosis of the latent complex, both in transfected cells and two cancer cell lines that natively express these integrins. Independent labeling of the prodomain, GF, and GARP shows that all three components are co-transferred to the integrin-expressing cell, and a TGF-{beta}1 mutant (RGE) that cannot bind integrins shows little transfer. Using a reporter system that tracks pathway activation in presenting, integrin-expressing, and bystander cells, we find that GF-neutralizing antibodies block downstream signaling more effectively in bystander cells than in the first two cell types that participate in trogocytosis. Blocking cleavage between the prodomain and the GF blocks signaling in bystander cells while still permitting signaling in trogocytosing cell types. Finally, we integrin-expressing cells that have taken up latent TGF-{beta}1 by trogocytosis can activate it and signal to bystander cells after the TGF-{beta}1 cells are removed, indicating that trogocytosis converts integrin-expressing cells into TGF-{beta} signaling relays. These findings identify a role for trogocytosis in regulating the specificity of TGF-{beta}1 activation and signaling, and reveal a novel function of integrins in controlling protein localization.

molecular biology↗

SOX9 binds TCFs to mediate Wnt/β catenin target gene activation

Activation of the Wnt/{beta}-catenin pathway regulates gene expression by promoting the formation of a {beta}-catenin-TCF complex on target gene chromatin. The transcription factor SOX9 antagonises Wnt signalling in many contexts through its ability to down-regulate {beta}-catenin protein levels. Here, we find that SOX9 promotes the proliferation of Wnt-driven colorectal cancer (CRC) cells. We identify multiple enhancers activated by SOX9 working in concert with the Wnt pathway. These enhancers are co-occupied by TCFs and SOX9 and contain TCF and SOX9 binding sites that are necessary for transcriptional activation. In addition, we identify a physical interaction between the DNA-binding domains of TCFs and SOX9 and show that TCF-SOX9 interactions are important for target gene regulation and CRC cell growth. Our work demonstrates a highly context-dependent effect of SOX9 on Wnt targets, with activation or repression being dependent on the presence or absence of SOX9 binding sites on Wnt-regulated enhancers respectively.

cancer biology↗